Cart
sales@molnova.com
GLP-1R modulator L7-028
CAS No. 2648317-95-5
GLP-1R modulator L7-028( —— )
Catalog No. M35193 CAS No. 2648317-95-5
GLP-1R modulator L7-028 is a variant that enhances affinity for GLP-1 and (cAMP) signaling.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 132 | In Stock |
|
| 10MG | 188 | In Stock |
|
| 25MG | 322 | In Stock |
|
| 50MG | 460 | In Stock |
|
| 100MG | 684 | In Stock |
|
| 200MG | 918 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGLP-1R modulator L7-028
-
NoteResearch use only, not for human use.
-
Brief DescriptionGLP-1R modulator L7-028 is a variant that enhances affinity for GLP-1 and (cAMP) signaling.
-
DescriptionGLP-1R modulator L7-028 is an allosteric modulator enhancing GLP-1 binding to GLP-1R via a transmembrane site (EC50 11.01 ± 2.73 μM).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetGlucagon Receptor
-
RecptorGlucagon Receptor | cAMP
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2648317-95-5
-
Formula Weight392.49
-
Molecular FormulaC24H28N2O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (254.78 mM; Ultrasonic )
-
SMILESO=C(Nc1cccc(c1)C(=O)N1CCCCC1)c1cccc(OC2CCCC2)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Wang J, et al. Allosteric Modulators Enhancing GLP-1 Binding to GLP-1R via a Transmembrane Site. ACS Chem Biol. 2021 Nov 19;16(11):2444-2452. ?
molnova catalog
related products
-
Avexitide acetate
Avexitide acetate (exendin 9-39) is a potent glucagon-like peptide 1 receptor (GLP-1R) antagonist for the study of post-obesity hypoglycemia.
-
BETP
BETP is an agonist of GLP-1 receptor (EC50s: 0.66 and 0.755 μM for human and rat GLP-1 receptor).
-
Orforglipron
Orforglipron (LY3502970; GLP-1 receptor agonist 1) is an orally available glucagon-like peptide (GLP-1) receptor agonist for the study of obesity and type 1 diabetes in adults.
